News

Candida colonization raises risk of Acinetobacter-based VAP


 

FROM MEDICAL MYCOLOGY

References

Acinetobacter baumanii was the most common cause of ventilator-associated pneumonia in ICU patients, and the risk of A. baumannii infection was significantly higher when airways were colonized with Candida species, based on data from 618 adults.

A. baumannii is a frequent cause of ventilator-associated pneumonia (VAP) in ICU patients, but its potential interactions with Candida species have not been well studied, wrote Dr. Xiaojiang Tan of Southern Medical University, Guangzhou, China, and colleagues (Med Mycol. 2016 Aug 1;54[6]:557-66. doi: 10.1093/mmy/myw009). The researchers reviewed data from 264 ICU patients on mechanical ventilation who had Candida species airway colonization and 354 who did not.

Overall, Candida was an independent risk factor for A. baumannii VAP; patients with Candida were significantly more likely than those without Candida to develop A. baumannii (23% vs. 15%). Other independent risk factors for A. baumannii VAP included the use of a central venous catheter and the use of mechanical ventilation for at least 7 days. Among patients on mechanical ventilation for at least 48 hours, Candida airway colonization occurred in 43%, and A. baumannii VAP occurred in 18%.

GrahamColm/Wikimedia Commons

Candida albicans showed an especially strong association with A. baumannii VAP; it was identified in 38% of cases, compared with 21% caused by non-albicans species.

No significant differences in hospital stay or in-hospital mortality were noted between Candida-colonized and noncolonized patients, and antifungal treatment had no apparent impact on the development of A. baumannii VAP, but antifungals were associated with higher in-hospital mortality (53% vs. 39%, P = .037).

The results were limited by the retrospective nature of the study and the use of data from a single center; thus, the relationship between Candida and A. baumannii VAP may not be generalizable, the researchers noted. However, “the strong independent association between the two suggests that Candida spp. growth from the lower respiratory tract in intubated patients could be an important indicator of the risk for VAP, and even that C. albicans airway colonization may play a role in subsequent development of A. baumannii VAP,” they wrote.

The researchers reported having no relevant financial conflicts.

Recommended Reading

Bezlotoxumab beats placebo at preventing recurrent C. difficile infections in high-risk patients
MDedge Internal Medicine
Building owners, managers must do more to prevent Legionnaires’ disease
MDedge Internal Medicine
Recurrent C. diff infection much more costly to treat
MDedge Internal Medicine
Hospital-acquired respiratory viruses cause significant morbidity, mortality
MDedge Internal Medicine
Primary care management of sepsis survivors does not improve mental health quality of life
MDedge Internal Medicine
Staffing, work environment drive VAP risk in the ICU
MDedge Internal Medicine
Seasonal variation not seen in C. difficile rates
MDedge Internal Medicine
New antibiotics targeting MDR pathogens are expensive, but not impressive
MDedge Internal Medicine
Experts emphasize scrupulous procedures for duodenoscopes, ERCP
MDedge Internal Medicine
Infections, antibiotics more common in type 2 diabetes
MDedge Internal Medicine